Results 291 to 300 of about 394,398 (350)
Some of the next articles are maybe not open access.
Pediatric Nephrology, 1996
Similar to findings in the nephrotic syndrome in humans, rats with the doxorubicin-induced nephrotic syndrome (which resembles minimal change disease) have reduced serum levels of insulin-like growth factor-I (IGF-I). This is mainly caused by glomerular ultrafiltration of IGF-I-containing binding protein complexes, primarily of a molecular weight of ...
S M, Feld, R, Hirschberg
openaire +2 more sources
Similar to findings in the nephrotic syndrome in humans, rats with the doxorubicin-induced nephrotic syndrome (which resembles minimal change disease) have reduced serum levels of insulin-like growth factor-I (IGF-I). This is mainly caused by glomerular ultrafiltration of IGF-I-containing binding protein complexes, primarily of a molecular weight of ...
S M, Feld, R, Hirschberg
openaire +2 more sources
Journal of Dairy Research, 1999
The mammary gland is an example of a tissue of epidermal origin that depends for the development of its characteristic morphology on underlying mesenchymal cells. The interaction between mesenchyme and epithelium appears to be mediated by polypetide growth factors.
Forsyth, Isabel A. +2 more
openaire +4 more sources
The mammary gland is an example of a tissue of epidermal origin that depends for the development of its characteristic morphology on underlying mesenchymal cells. The interaction between mesenchyme and epithelium appears to be mediated by polypetide growth factors.
Forsyth, Isabel A. +2 more
openaire +4 more sources
Hormone and Metabolic Research, 1989
Receptor-mediated endocytosis may represent an important mechanism whereby peptide hormones exert their biological effects. The ability of recombinant insulin-like growth factor (IGF)-I to be internalized by cultured cells was evaluated in BRL-3A2 cells, a rat liver-derived cell line which lacks insulin receptors.
E S, Geary, R G, Rosenfeld, A R, Hoffman
openaire +2 more sources
Receptor-mediated endocytosis may represent an important mechanism whereby peptide hormones exert their biological effects. The ability of recombinant insulin-like growth factor (IGF)-I to be internalized by cultured cells was evaluated in BRL-3A2 cells, a rat liver-derived cell line which lacks insulin receptors.
E S, Geary, R G, Rosenfeld, A R, Hoffman
openaire +2 more sources
Insulin‐like growth factor I in growing thoroughbreds
Journal of Animal Physiology and Animal Nutrition, 2007SummaryThe objective of this longitudinal study was to characterize growth and plasma insulin‐like growth factor I (IGF‐I) concentrations in pasture‐raised thoroughbreds fed two sources of dietary energy. Mares and foals were randomly assigned to either a sugar and starch (SS) or fat and fibre (FF)‐rich feed, and plasma IGF‐I and growth were measured ...
W B, Staniar +3 more
openaire +2 more sources
Insulin-Like Growth Factor I: Pros and Cons of a Bioassay
Hormone Research in Paediatrics, 2011Background: Insulin-like growth factor I (IGF-I) immunoassays are primarily used to estimate IGF-I status. Recently an IGF-I-specific kinase receptor activation assay (KIRA) was developed as an alternative method for measuring IGF-I bioactivity. When compared with IGF-I immunoassays, the IGF-I KIRA has the theoretical advantage of measuring the net ...
openaire +2 more sources
Insulin-Like Growth Factor-I in Celiac Disease
Journal of Pediatric Gastroenterology and Nutrition, 1994To contribute to the description of the physiopathological mechanisms of celiac disease, changes in insulin-like growth factor I (IGF-I) were followed-up in 21 children suspected of suffering from celiac disease. Thirteen children were suffering from celiac disease according to the original criteria of the European Society of Paediatric ...
B, Weile +3 more
openaire +2 more sources
Exercise and Circulating Insulin-Like Growth Factor I
Hormone Research in Paediatrics, 2004Determinations of serum concentrations of total insulin-like growth factor I (tIGF-I) are important in the diagnosis, monitoring of treatment and safety evaluation of patients with growth disorders and/or metabolic disease. It is well established that tIGF-I status varies over time.
Ulrika, Berg, Peter, Bang
openaire +2 more sources
Peptides, 1993
Recombinant human insulin-like growth factor I (hIGF-I) was reacted with azidobenzoyl hydroxysuccinimide to produce a mixture of photoactive hIGF-I derivatives. The mixture was purified by reversed-phase HPLC to yield three mono-substituted azidobenzoyl hIGF-Is.
Cecil C. Yip +3 more
openaire +1 more source
Recombinant human insulin-like growth factor I (hIGF-I) was reacted with azidobenzoyl hydroxysuccinimide to produce a mixture of photoactive hIGF-I derivatives. The mixture was purified by reversed-phase HPLC to yield three mono-substituted azidobenzoyl hIGF-Is.
Cecil C. Yip +3 more
openaire +1 more source
Insulin-like growth factor-I and diabetes. A review
Growth Hormone & IGF Research, 1998Although diabetes is a heterogeneous condition, IGF-I has been shown to improve glycaemic control and reduce insulin requirements in both IDDM and NIDDM. In IDDM, the therapeutic rationale for IGF-I is as a replacement therapy "topping up" low circulating IGF-I levels.
Simpson, H L +2 more
openaire +3 more sources
Effects of Insulin‐Like Growth Factor I in Man
Acta Paediatrica, 1990ABSTRACT. A 6‐day period of subcutaneous infusion with recombinant human insulin‐like growth factor I in three healthy male volunteers resulted in an increase in the ratio of insulin to C‐peptide levels and significant decreases in triglyceride levels and the ratio of total to high density lipoprotein—cholesterol in serum.
Guler HP, Schmid C, Zapf J, Froesch ER
openaire +3 more sources